Reaction Details Report a problem with these data
Target
Protachykinin-1
Ligand
BDBM50252513
Substrate
n/a
Ki
1000±n/a nM
Comments
PDSP_1600
Citation
 Schotte, A; Janssen, PF; Gommeren, W; Luyten, WH; Van Gompel, P; Lesage, AS; De Loore, K; Leysen, JE Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57-73 (1996) [PubMed]  Article 
Target
Name:
Protachykinin-1
Synonyms:
NKA | NKNA | Protachykinin-1 | Substance P | TAC1 | TAC2 | TKN1_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
15006.99
Organism:
Homo sapiens (Human)
Description:
Substance P 0 HUMAN::P20366
Residue:
129
Sequence:
MKILVALAVFFLVSTQLFAEEIGANDDLNYWSDWYDSDQIKEELPEPFEHLLQRIARRPKPQQFFGLMGKRDADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLMGKRALNSVAYERSAMQNYERRR
  
Inhibitor
Name:
BDBM50252513
Synonyms:
3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | 9-OH-risperidone | 9-hydroxy risperidone | CHEMBL1621 | Invega | PALIPERIDONE
Type:
Small organic molecule
Emp. Form.:
C23H27FN4O3
Mol. Mass.:
426.4839
SMILES:
Cc1nc2C(O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12
Structure:
Search PDB for entries with ligand similarity: